Equities

Eurocine Vaccines AB

Eurocine Vaccines AB

Actions
  • Price (SEK)0.0916
  • Today's Change0.045 / 95.73%
  • Shares traded107.39m
  • 1 Year change-73.38%
  • Beta0.8159
Data delayed at least 15 minutes, as of Apr 18 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • EUCI:AKT price rises above 200-day moving average to 0.0708 at 11:48 BST
  • EUCI:AKT price rises above 200-day moving average to 0.068 at 14:53 BST
  • EUCI:AKT price moved over +5.85% to 0.0688
  • EUCI:AKT price rises above 200-day moving average to 0.0688 at 10:02 BST

Key statistics

On Thursday, Eurocine Vaccines AB (EUCI:AKT) closed at 0.0916, 527.40% above the 52 week low of 0.0146 set on Apr 16, 2024.
52-week range
Today
0.0146Apr 16 20240.8681Jul 28 2023
Open0.0502
High0.11
Low0.045
Bid0.0916
Offer0.0916
Previous close0.0468
Average volume22.24m
Shares outstanding191.91m
Free float14.35m
P/E (TTM)--
Market cap12.67m SEK
EPS (TTM)-0.1472
SEK
Data delayed at least 15 minutes, as of Apr 18 2024 17:00 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.